Review
doi: 10.1016/0041-3879(84)90079-5.
The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis
- PMID: 6385429
- DOI: 10.1016/0041-3879(84)90079-5
Item in Clipboard
Review
The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis
Tubercle.
1984 Sep.
No abstract available
Similar articles
-
Lack of relationship between hepatic toxicity and acetylator phenotype in three thousand South Indian patients during treatment with isoniazid for tuberculosis.Am Rev Respir Dis. 1984 Jan;129(1):58-61. doi: 10.1164/arrd.1984.129.1.58. Am Rev Respir Dis. 1984. PMID: 6367570 Clinical Trial.
-
[The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis].Rev Mal Respir. 1984;1(4):207-19. Rev Mal Respir. 1984. PMID: 6505358 French.
-
[The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis].Cas Lek Cesk. 1984 Feb 10;123(6):158-64. Cas Lek Cesk. 1984. PMID: 6697364 Czech. No abstract available.
-
Variations between individuals and populations in the acetylation of isoniazid and its significance for the treatment of pulmonary tuberculosis.Clin Pharmacol Ther. 1976 May;19(5 Pt 2):610-25. doi: 10.1002/cpt1976195part2610. Clin Pharmacol Ther. 1976. PMID: 773583 Review.
-
[Clinical pharmacology of isoniazid (a review of the literature)].Probl Tuberk. 1979 Jan;(1):18-26. Probl Tuberk. 1979. PMID: 368763 Review. Russian. No abstract available.
Cited by
-
Acetylator status of kwashiorkor children in Ibadan (south-west Nigeria).Eur J Drug Metab Pharmacokinet. 1990 Jan-Mar;15(1):57-62. doi: 10.1007/BF03190128. Eur J Drug Metab Pharmacokinet. 1990. PMID: 2384118
-
Isoniazid protects mice against endotoxin lethality without influencing tumor necrosis factor synthesis and release.Antimicrob Agents Chemother. 1991 Aug;35(8):1666-8. doi: 10.1128/AAC.35.8.1666. Antimicrob Agents Chemother. 1991. PMID: 1929338 Free PMC article.
-
Meta-analysis of clinical studies supports the pharmacokinetic variability hypothesis for acquired drug resistance and failure of antituberculosis therapy.Clin Infect Dis. 2012 Jul;55(2):169-77. doi: 10.1093/cid/cis353. Epub 2012 Mar 30. Clin Infect Dis. 2012. PMID: 22467670 Free PMC article. Clinical Trial.
-
Pharmacokinetics of first-line tuberculosis drugs in Tanzanian patients.Antimicrob Agents Chemother. 2013 Jul;57(7):3208-13. doi: 10.1128/AAC.02599-12. Epub 2013 Apr 29. Antimicrob Agents Chemother. 2013. PMID: 23629715 Free PMC article.
-
The influence of dose and N-acetyltransferase-2 (NAT2) genotype and phenotype on the pharmacokinetics and pharmacodynamics of isoniazid.Eur J Clin Pharmacol. 2007 Jul;63(7):633-9. doi: 10.1007/s00228-007-0305-5. Epub 2007 May 16. Eur J Clin Pharmacol. 2007. PMID: 17505821
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical